CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Class A	Common Class B	Common Stock	Common Stock Common Class A	Common Stock Common Class B	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022					4,705,328	134,839
Beginning balance at Dec. 31, 2022	$ 520,619				$ 47	$ 1	$ 1,678,247	$ (1,160,618)	$ 2,942
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(35,901)							(35,901)
Compensation expense related to granting of stock awards (in shares)					195,724
Compensation expense related to granting of stock awards	1,949				$ 2		1,947
Purchase of vested employee restricted stock units (in shares)					(27,072)
Purchase of vested employee restricted stock units	(127)						(127)
Payment of dividends on common stock	(60)						(60)
Dividend equivalents, net of forfeitures	22							22
Net unrealized gain (loss) on derivatives	(840)								(840)
Ending balance (in shares) at Mar. 31, 2023					4,873,980	134,839
Ending balance at Mar. 31, 2023	485,662				$ 49	$ 1	1,680,007	(1,196,497)	2,102
Beginning balance (in shares) at Dec. 31, 2022					4,705,328	134,839
Beginning balance at Dec. 31, 2022	520,619				$ 47	$ 1	1,678,247	(1,160,618)	2,942
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ (161,705)
Repurchase of common stock (in shares)	0
Net unrealized gain (loss) on derivatives	$ (1,231)
Ending balance (in shares) at Jun. 30, 2023					4,865,759	134,839
Ending balance at Jun. 30, 2023	360,574				$ 49	$ 1	1,681,074	(1,322,261)	1,711
Beginning balance (in shares) at Mar. 31, 2023					4,873,980	134,839
Beginning balance at Mar. 31, 2023	485,662				$ 49	$ 1	1,680,007	(1,196,497)	2,102
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(125,802)							(125,802)
Compensation expense related to granting of stock awards (in shares)					(7,449)
Compensation expense related to granting of stock awards	1,049						1,049
Repurchase of common stock (in shares)				(215)
Repurchase of common stock	(1)						(1)
Purchase of vested employee restricted stock units (in shares)					(557)
Purchase of vested employee restricted stock units	(2)						(2)
Dividend equivalents, net of forfeitures	38							38
Payment of dividends on common stock	21						21
Net unrealized gain (loss) on derivatives	(391)								(391)
Ending balance (in shares) at Jun. 30, 2023					4,865,759	134,839
Ending balance at Jun. 30, 2023	360,574				$ 49	$ 1	1,681,074	(1,322,261)	1,711
Beginning balance (in shares) at Dec. 31, 2023		4,867,170	134,839		4,867,170	134,839
Beginning balance at Dec. 31, 2023	(614,753)				$ 49	$ 1	1,682,467	(2,297,270)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(1,852)							(1,852)
Compensation expense related to granting of stock awards	304						304
Purchase of vested employee restricted stock units (in shares)					(7,411)
Purchase of vested employee restricted stock units	0
Ending balance (in shares) at Mar. 31, 2024					4,859,759	134,839
Ending balance at Mar. 31, 2024	(616,301)				$ 49	$ 1	1,682,771	(2,299,122)	0
Beginning balance (in shares) at Dec. 31, 2023		4,867,170	134,839		4,867,170	134,839
Beginning balance at Dec. 31, 2023	(614,753)				$ 49	$ 1	1,682,467	(2,297,270)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ 1,079
Repurchase of common stock (in shares)	0
Net unrealized gain (loss) on derivatives	$ 0
Ending balance (in shares) at Jun. 30, 2024		4,852,895	134,839		4,852,895	134,839
Ending balance at Jun. 30, 2024	(612,991)				$ 49	$ 1	1,683,150	(2,296,191)	0
Beginning balance (in shares) at Mar. 31, 2024					4,859,759	134,839
Beginning balance at Mar. 31, 2024	(616,301)				$ 49	$ 1	1,682,771	(2,299,122)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	2,931							2,931
Compensation expense related to granting of stock awards	379						379
Purchase of vested employee restricted stock units (in shares)					(6,864)
Purchase of vested employee restricted stock units	0
Net unrealized gain (loss) on derivatives	0
Ending balance (in shares) at Jun. 30, 2024		4,852,895	134,839		4,852,895	134,839
Ending balance at Jun. 30, 2024	$ (612,991)				$ 49	$ 1	$ 1,683,150	$ (2,296,191)	$ 0